ZWI Therapeutics
PrivateLast Round
Series A
Jan 24, 2024
Total Funding Raised
$10M
Company Overview
ZWI Therapeutics is a biotechnology company that develops protein therapeutics using proprietary polycarboxybetaine polymer technology to enhance safety and efficacy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZWI Therapeutics Comparables
Compare ZWI Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sanofi | 71% | |
| Nektar Therapeutics | 71% | |
| Serina Therapeutics Inc | 69% | |
ZWI Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 24, 2024 |
ZWI Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Co-Win Ventures | Series A |
| Sherpa Healthcare Partners | Series A |
ZWI Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ZWI Therapeutics's valuation, stock price, and market status.